|
|
|
51-200 employees
View all
|
|
Biotechnology
|
|
725 San Aleso Ave, Sunnyvale, California 94085, US
|
|
Maxygen is a biopharmaceutical company focused on developing improved versions of protein drugs through internal development and external collaborations and other arrangements. We use the MolecularBreeding™ directed evolution technology platform, along with ancillary technologies, and extensive protein modification expertise to pursue the creation of biosuperior proteins.
Maxygen operates substantially all of its research and development operations through Perseid Therapeutics LLC, or Perseid, a majority-owned subsidiary established in September 2009 in connection with a joint venture arrangement with Astellas Pharma Inc., or Astellas. Perseid is focused on the discovery, research and development of multiple protein pharmaceutical programs, including CTLA-4 Ig product candidates that are designed to be superior, next-generation CTLA-4 Ig therapeutics for the treatment of a broad array of autoimmune disorders, including rheumatoid arthritis, and transplant rejection.
|
Maxygen Email Formats | Example Email Formats | Percentage |
---|---|---|
{first}.{last} | [email protected] |
85.71%
|
The widely used Maxygen email format is {first}.{last} (e.g. [email protected]) with 85.71% adoption across the company.
To contact Maxygen customer service number in your country click here to find.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.